NCT01075256View on ClinicalTrials.gov

Dose Response of a Tubule Occlusion Agent

PHASE4CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Dentine HypersensitivityDental Pain
Interventions
DEVICE

5% calcium sodium phosphosilicate toothpaste

Low concentration calcium sodium phosphosilicate tubule occlusion agent

DEVICE

7.5% calcium sodium phosphosilicate toothpaste

High concentration calcium sodium phosphosilicate tubule occlusion agent

DEVICE

Placebo toothpaste

Placebo toothpaste

Trial Locations (1)

46825

University Park Research Center (UPRC), Fort Wayne

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY